According to Zydus Lifesciences's latest financial reports and stock price the company's current Operating Margin is 16.11%. At the end of 2023 the company had an Operating Margin of 15.34%.
Year | Operating Margin | Change |
---|---|---|
2023 | 15.34% | -19.84% |
2022 | 19.14% | 24.17% |
2021 | 15.42% | 42.38% |
2020 | 10.83% | -42.06% |
2019 | 18.69% | -7.01% |
2018 | 20.09% | 17.55% |
2017 | 17.09% | -20.81% |
2016 | 21.59% | 29.2% |
2015 | 16.71% | 28.11% |
2014 | 13.04% | 2.54% |
2013 | 12.72% | -18.48% |
2012 | 15.60% | -17.31% |
2011 | 18.87% | 15.2% |
2010 | 16.38% | 26.79% |
2009 | 12.92% | -9.48% |
2008 | 14.27% | -6.96% |
2007 | 15.34% | 25.4% |
2006 | 12.23% | 10.91% |
2005 | 11.03% | -12.91% |
2004 | 12.67% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.